Morning Buzz: Facebook (NASDAQ:FB), Halliburton Company (NYSE:HAL), Cubist Pharmaceuticals (NASDAQ:CBST), Shire PLC (ADR) (NASDAQ:SHPG), Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ)

Facebook Inc. (NASDAQ:FB) has built its own networking switches crucial hardware devices that transport Internet information between machines – to power its increasing number of services. Facebook Inc. (NASDAQ:FB) stock opened today at $64.46 and is currently trading at $63.75. The stock showed a positive weekly performance of 0.08%.

Equities researchers at Howard Weil upped their target price on shares of Halliburton Company (NYSE:HAL) from $73.00 to $75.00 in a research report issued on Wednesday. The firm currently has a “sector outperform” rating on the stock. Howard Weil’s target price would indicate a potential upside of 8.73% from the stock’s previous close. Halliburton Company (NYSE:HAL) stock opened at $69.41, in current trading session and currently is at $69.82, by gaining 1.22%. The 52 week range of $40.12 – $69.99. Company’s market capitalization is 58.96 billion.

Cubist Pharmaceuticals (NASDAQ:CBST), which is expecting the FDA to approve its antibiotic candidate Sivextro today, received encouraging news yesterday on another pipeline candidate, ceftolozane/tazobactam. The FDA stated that it will review Cubist’s New Drug Application (NDA) for ceftolozane/tazobactam on a priority basis and assigned a target date of Dec 21, 2014. We expect the market to react positively to the news on ceftolozane/tazobactam.  Cubist Pharmaceuticals Inc. (NASDAQ:CBST) stock is currently trading at $71.37. The EPS of the stock is -0.05. Company’s market capitalization is 5.37 billion.

Shire PLC (ADR) (NASDAQ:SHPG) surged 20% after the European biopharmaceutical company rejected a buyout offer from competitor AbbVie.  Shire PLC (ADR) (NASDAQ:SHPG) stock opened the session at $223.23, and now is at $227.91. The 52 week range of Shire PLC (ADR) (NASDAQ:SHPG) stock remained $91.81 – $229.44 and the day range was $221.78 – $229.44.

Jazz Pharmaceuticals plc – (NASDAQ:JAZZ) EVP Fintan Keegan unloaded 3,750 shares of Jazz Pharmaceuticals plc – stock on the open market in a transaction dated Tuesday, June 17th. The shares were sold at an average price of $150.00, for a total value of $562,500.00. Following the completion of the transaction, the executive vice president now directly owns 33,272 shares of the company’s stock, valued at approximately $4,990,800. Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) stock opened today at $150.33 and is currently trading at $152.75. The stock showed a positive weekly performance of 5.35%.